When did GENMAB A/S -SP ADR (GMAB) report earnings last quarter?
GENMAB A/S -SP ADR (GMAB) last reported earnings on 2/18/2026.
NASDAQ:GMAB • US3723032062
Past quarterly earnings results for GENMAB A/S -SP ADR (GMAB), including EPS and revenue actuals, analyst estimates, and surprise percentages. This page focuses on historical performance (not forecasts).
EPS & Revenue History (in USD): Actual vs estimated values, surprises, q2q growth and acceleration numbers quarterly history.
| Quarter | EPS | EPS Est | EPS Surprise | EPS Q2Q | Revenue | Revenue Est | Revenue Surprise | Revenue Q2Q |
|---|---|---|---|---|---|---|---|---|
| Q4 2025 | 0.22 | 0.36 | -39.11% | -75.02% | 1.058B | 1.056B | 0.19% | 14.88% |
| Q3 2025 | 0.66 | 0.49 | 36.36% | 121.44% | 1.022B | 1.011B | 1.09% | -81.55% |
| Q2 2025 | 0.56 | 0.44 | 25.14% | 73.04% | 925M | 938.97M | -1.49% | -82.88% |
| Q1 2025 | 0.31 | 0.21 | 49.64% | 3.77% | 715.002M | 774.29M | -7.66% | -82.74% |
| Q4 2024 | 0.87 | 0.37 | 134.67% | 511.09% | 920.973M | 904.1M | 1.87% | -80.31% |
| Q3 2024 | 0.30 | 0.34 | -10.91% | -38.15% | 5.54B | 840.67M | 559.00% | 16.78% |
| Q2 2024 | 0.32 | 0.31 | 2.30% | 3.98% | 5.402B | 755.36M | 615.16% | 28.68% |
| Q1 2024 | 0.30 | 0.18 | 69.78% | 494.29% | 4.143B | 560.12M | 639.66% | 45.16% |
| Q4 2023 | 0.14 | 0.35 | -59.06% | 15.92% | 4.678B | 675.52M | 592.50% | 563.73% |
| Q3 2023 | 0.48 | 0.30 | 58.98% | -11.00% | 4.744B | 650.76M | 628.99% | 757.11% |
| Q2 2023 | 0.31 | 0.30 | 1.92% | -26.58% | 4.198B | 616.41M | 581.04% | 826.99% |
| Q1 2023 | 0.05 | 0.08 | -38.26% | -53.45% | 2.854B | 409.55M | 596.86% | 793.37% |
| Q4 2022 | 0.12 | 0.40 | -68.82% | -27.62% | 704.807M | 696.28M | 1.22% | 79.48% |
| Q3 2022 | 0.54 | 0.26 | 110.03% | 148.25% | 553.49M | 483.66M | 14.44% | 51.13% |
| Q2 2022 | 0.42 | 0.20 | 108.67% | 445.88% | 452.865M | 419.69M | 7.90% | 41.79% |
| Q1 2022 | 0.11 | 0.08 | 33.66% | -60.52% | 319.465M | 298.02M | 7.20% | 24.69% |
| Q4 2021 | 0.17 | 0.13 | 29.34% | 18.61% | 392.698M | 392.42M | 0.07% | 19.91% |
| Q3 2021 | 0.22 | 0.13 | 62.88% | 69.13% | 366.23M | 346.19M | 5.79% | 35.32% |
| Q2 2021 | 0.08 | 0.08 | -0.39% | -90.09% | 319.399M | 271.16M | 17.79% | -60.30% |
| Q1 2021 | 0.28 | 0.07 | 301.09% | 345.81% | 256.206M | 229.36M | 11.70% | 94.60% |
| Q4 2020 | 0.14 | 0.13 | 13.91% | - | 327.506M | 299.13M | 9.49% | - |
| Q3 2020 | 0.13 | 0.10 | 28.91% | - | 270.63M | 238.59M | 13.43% | - |
| Q2 2020 | 0.78 | 0.88 | -11.58% | - | 804.589M | 853.76M | -5.76% | - |
| Q1 2020 | 0.06 | 0.02 | 199.67% | - | 131.659M | 133.72M | -1.54% | - |
Notes
GENMAB A/S -SP ADR (GMAB) last reported earnings on 2/18/2026.
GENMAB A/S -SP ADR (GMAB) missed EPS estimates and beat revenue estimates in the most recent quarter.
In the last 4 quarters, GENMAB A/S -SP ADR (GMAB) has beaten EPS estimates in 3 out of 4 releases.